Table 3 Association of incident NHL with incident breast cancer according to the time after diagnosis.
From: Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study
Incidence of non-Hodgkin lymphoma | Non-Hodgkin lymphoma | DLBCL | Follicular lymphoma | Mature T/NK-cell lymphomas | ALCL | Other NHL* | |
---|---|---|---|---|---|---|---|
No breast cancer | Reference | Reference | Reference | Reference | Reference | Reference | |
<1 year after diagnosis | HR (95% CI) | 2.59 (1.79, 3.74) | 2.36 (1.05, 5.29) | 7.20 (2.63, 19.70) | 3.62 (1.15, 11.40) | – | 2.20 (1.34, 3.61) |
P-value | <0.01 | 0.04 | <0.01 | 0.03 | – | <0.01 | |
1 to < 3 years after diagnosis | HR (95% CI) | 1.62 (1.13, 2.31) | 0.68 (0.22, 2.12) | 4.34 (1.59, 11.89) | 3.52 (1.44, 8.63) | 9.71 (2.22, 42.51) | 1.53 (0.97, 2.41) |
P-value | <0.01 | 0.51 | <0.01 | <0.01 | <0.01 | 0.07 | |
3 to < 5 years after diagnosis | HR (95% CI) | 1.41 (0.91, 2.19) | 1.19 (0.44, 3.19) | 1.48 (0.20, 10.63) | 1.90 (0.47, 7.70) | 6.87 (0.91, 52.14) | 1.43 (0.83, 2.47) |
P-value | 0.13 | 0.73 | 0.70 | 0.37 | 0.06 | 0.20 | |
≥5 years after diagnosis | HR (95% CI) | 1.29 (0.87, 1.91) | 1.05 (0.43, 2.53) | 2.12 (0.58, 8.66) | 2.11 (0.67, 6.66) | 10.73 (2.42, 47.56) | 1.22 (0.73, 2.03) |
P-value | 0.21 | 0.92 | 0.30 | 0.20 | <0.02 | 0.45 |